BerryQi Boysenberry & Apple Powde

                                   
BerriQi is a scientifically tested, patented respiratory health ingredient derived from New Zealand-grown boysenberries and apples. This proprietary blend, developed in llaboration with Plant and Food Research NZ, combines the unique bioactive compounds of these fruits to naturally support lung health by reducing inflammation, mucus roduction, and tissue damage. BerriQi is available as a liquid concentrate or powder, making it versatile for dietary supplement formulations.

Health Outcomes

• Reduces lung inflammation and mucus overproduction.

• Repairs damaged lung tissue and reverses scarring promoting airway remodelling.

• Supports fibrolytic macrophages to restore lung elasticity and capacity.

• Improves breathing parameters within one hour of consumption in acute cases.

• 6 In-Vivo Models: Proven efficacy in acute, chronic therapeutic, and chronic recovery models of airway inflammation in mice.

• 6 In-Vitro Studies: Demonstrated antiinflammatory effects on human lung cells.

• 6 In-Vitro Studies: Demonstrated antiinflammatory effects on human lung cells.

• 2 Clinical Trials: New clinical studies confirm preclinical results, showing significant improvements in respiratory health markers. Ongoing clinical in children.

What Makes BerriQi Unique?

BerriQi’s potency lies in its bioactive compounds: anthocyanins (from boysenberries), ellagitannins, and procyanidins (from apples). These work synergistically to:

• Promote macrophage polarization from M1 (pro-inflammatory) to M2 (anti-inflammatory) states, accelerating tissue repair.

• Reduce collagen deposition and fibrosis, restoring lung flexibility.

• Inhibit key inflammatory pathways (e.g., NF-kB) while enhancing antioxidant activity.